Ronald Aldridge - PAREXEL International Sr. Director, Investor Relations

PRXL -- USA Stock  

null 88.06  0.04  0.0454%

  Director
We currently do not have informatin regarding Ronald Aldridge. This executive tanure with PAREXEL International Corp is not currenlty determined.
  Director Since 2016      
781 487-9900  http://www.parexel.com

Management Efficiency

The company has return on total asset (ROA) of 6.72 % which means that it generated profit of $6.72 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 16.93 % meaning that it created $16.93 on every $100 dollars invested by stockholders.
The company currently holds 671.5M in liabilities with Debt to Equity (D/E) ratio of 105.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. PAREXEL International has Current Ratio of 1.42 which is within standard range for the sector.

Similar Executives

Showing few of many executives

DIRECTOR Since

Michael TrimbleOrigin Agritech Limited
2006
Michael BrownRegeneron Pharmaceuticals
1991
Elaine UllianVertex Pharmaceuticals Incorpor
2011
Shan FuSinovac Biotech Ltd
N/A
Sanjay KhoslaZoetis
2013
Pengfei LiSinovac Biotech Ltd
2018
Kalpana MorpariaDr Reddys Laboratories Ltd
2007
Ashok GangulyDr Reddys Laboratories Ltd
2009
Alfred GilmanRegeneron Pharmaceuticals
1990
Rolf ClassonPerrigo Company plc
2017
Terrence KearneyVertex Pharmaceuticals Incorpor
2011
Linda RhodesZoetis
2017
Margaret McGlynnVertex Pharmaceuticals Incorpor
2011
Frank DAmelioZoetis
2016
Arthur RyanRegeneron Pharmaceuticals
2003
Michael JandernoaPerrigo Company plc
2007
Gregory NordenZoetis
2013
Prasad MenonDr Reddys Laboratories Ltd
2019
William YoungVertex Pharmaceuticals Incorpor
2014
Guowei WangSinovac Biotech Ltd
2018
Jeffrey SmithPerrigo Company plc
2017

Entity Summary

PAREXEL International Corporationration, a biopharmaceutical services company, offer clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology solutions and services for pharmaceutical, biotechnology, and medical device industries worldwide. PAREXEL International Corp (PRXL) is traded on NASDAQ in USA and employs 18,600 people.

PAREXEL International Leadership Team

Michelle Graham, Chief Human Resource Officer, Senior Vice President
Ulf Schneider, Chief Administrative Officer, Senior Vice President
Thomas Senderovitz, Senior Vice President - Clinical Research Services
Dana Callow, Presiding Independent Director
Emma Reeve, Interim CFO, Corporate Vice President Controller
Josef Rickenbach, Founder, Chairman and CEO
Patrick Fortune, Independent Director
Eduard Holdener, Independent Director
Simon Harford, CFO, Senior Vice President
Joshua Schultz, Senior Vice President-Worldwide Head of PAREXEL Access
Gadi Saarony, Senior Vice President - Clinical Research Services
Ellen Zane, Director, Member of Compensation Committee, Member of HR Committee, CEO of Tufts Medical Center and President of Tufts Medical Center
Christian Dreger, Senior Vice President - Parexel Access and Parexel Consulting
Xavier Flinois, President - Perceptive Informatics
Douglas Batt, Sr. VP, General Counsel and Secretary
Sybrand Pretorius, Senior Vice President Chief Scientific Officer
Maykin Ho, Director
Richard Love, Independent Director
Ronald Aldridge, Sr. Director, Investor Relations
Mark Goldberg, President COO
Roland Andersson, Senior Vice President - Clinical Research Services
Christopher Lindop, Independent Director
Ingo Bank, CFO and Sr. VP
David Godwin, Senior Vice President-Global Business

Stock Performance Indicators

Current Sentiment - PRXL

PAREXEL International Investor Sentiment

Most of Macroaxis users are at this time bullish on PAREXEL International Corp. What is your perspective on investing in PAREXEL International Corp? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Currently Active Assets on Macroaxis

TWTR   
Purchased over 50 shares of
few hours ago
Traded for 1.0
MGTI   
Purchased over 50 shares of
few hours ago
Traded for 1.0
PVCT   
Purchased over 10K shares of
few hours ago
Traded for 1.0
BTSC   
Purchased over 10K shares of
few hours ago
Traded for 1.0
ALNY   
Purchased few shares of
few hours ago
Traded for 1.0
Additionally take a look at Your Equity Center. Please also try Aroon Oscillator module to analyze current equity momentum using aroon oscillator and other momentum ratios.
Search macroaxis.com